Strategic, fractional, and project-based CFO leadership for founder-led and growth-stage companies navigating scale, profitability, operational complexity, and exit readiness. The same playbook that took Medicx Health from $15M to a $95M exit.
I work with a small number of CEOs, founders, and PE operating partners at companies where finance has to do more than report... it has to lead. The common thread: scaling toward a meaningful capital event or exit.
Pre-Series A through Series B founders building real CFO discipline before the next capital event. Cash visibility, unit economics, board-grade reporting, and the financial infrastructure to support what's next.
Series B through pre-exit companies scaling past founder-built finance into exit-ready infrastructure. Pricing, unit economics, FP&A maturity, and the operating discipline to sustain growth without breaking the model.
Companies positioning for transaction in 24 to 60 months, in active turnaround, or under PE ownership. EBITDA expansion, transaction prep, and the kind of financial story that holds up to PE and strategic diligence.
Engagements are flat-fee, scoped, and outcome-driven. Hourly billing creates clock-watching in conversations that should be strategic. Retainers come with monthly cadence; projects come with defined deliverables and timelines.
Joined Medicx Health as CFO in 2019 facing three consecutive years of declining revenue and three months of cash on hand. Led a complete financial and operational transformation: rebuilt the operating model, redesigned product-level P&L and pricing, eliminated company debt, and modernized the financial infrastructure with NetSuite.
Took the company from declining to record-setting revenue, with EBITDA expanding from break-even to over 20% margins. Led the company through a successful sale to OptimizeRx in October 2023.
Selected from a network of CEOs, C-suite executives, and senior operators across healthcare, insurance, technology, and services. Sourced from LinkedIn recommendations.
Scott's ability to uncover data-driven insights is unparalleled. His relentless pursuit of accuracy and precision has significantly contributed to our company's success. His leadership has been instrumental in steering our company toward growth and stability.
Scott elevated the accounting and finance function to a whole new level. He created efficiencies, tackled complex issues, and enhanced the insights finance was able to provide. He played a key role in the eventual sale of the business, helping lead a successful exit and post-acquisition integration.
Scott was really good at challenging the status quo, and helping people understand downstream implications of decisions as they relate to the finances, optics, and financial health of the organization. He is passionate about driving change in healthcare, and that comes through.
Scott was a key member of the Select Customer team. He provided insightful analysis on a timely basis to help in decision making and management of the business. He helped me a great deal and I would recommend him strongly.
Scott is a strong analytical and financial partner. He always provided top notch insight and expertise. What made Scott unique amongst his peers was his high intellectual curiosity and desire to understand the business more deeply. He is an outstanding partner and would be an asset to any organization.
Scott made significant contributions to any endeavor he was engaged in. He possesses a rare combination of financial acumen, innovative thinking, and a collaborative style.
Scott is a very proactive, collaborative and effective business partner. Though always focused on bottom line goals, his overall business acumen enabled him to serve as a valuable resource in offering viable alternatives to reaching corporate goals. I would not hesitate in recommending Scott for a financial or other executive management position.
Scott played a critical role in assessing the costs and benefits of critical business initiatives to increase organizational effectiveness. He was particularly helpful in identifying KPIs to measure the impact of process and organizational changes. I highly recommend Scott to any organization interested in driving meaningful change to improve competitive advantage.
Scott possesses a remarkable depth of knowledge and expertise in FP&A. His strategic insights and analytical acumen were instrumental in guiding our team to success on numerous projects, including the pivotal role he played in the company's merger with OPRX.
Scott is one of the most disciplined, committed, and results-oriented people I have ever worked with. He has a great ability to uncover opportunities hidden in data and is driven to help the entire team succeed. Scott is a terrific judge of ability and talent.
Senior fractional finance done right is half thought partnership and half hands-on execution. I lean on data, AI tooling, and a CFO operator's instincts to make the financial picture clear, then move quickly.
Every engagement starts with a structured assessment. Cash, unit economics, KPIs, and the gaps between current state and exit-ready. No generic playbooks.
I've sat in the CFO seat through scaling, turnaround, and a successful exit. Recommendations come with the EBITDA, cash, and risk implications already worked through.
Modern CFO work demands modern tooling. I bring AI-augmented modeling, scenario analysis, and reporting workflows that compress what used to take weeks.
Every financial decision is filtered through the question of how it shows up in diligence. Clean data, defensible numbers, and a story that holds up to PE and strategic scrutiny.
"Companies don't get sold for what they did. They get sold for what the buyer believes they can do next."
I'm a strategic CFO with 25-plus years of experience driving financial transformation, capital strategy, and operational scale across high-growth and complex organizations. I'm best known for the work that took Medicx Health from a struggling growth-stage business to a $95M sale to OptimizeRx in 2023.
Through Magnano Advisory, I partner with a select group of startup, hyper-growth, and exit-stage companies across healthcare, technology, insurance, services, and PBM. The work spans full fractional CFO engagements, project-based financial transformation, and board-level strategic advisory. The common thread is always the same: building the financial infrastructure that supports scale and stands up to a sophisticated buyer.
I'm based in the Phoenix area, work nationally, and partner with founders, CEOs, boards, and PE operating partners across the country.
Perspective on exit strategy, FP&A, capital structure, and the realities of scaling a private company toward transaction. New writing every week or two.
Customer concentration, contract durability, and the gap between management EBITDA and QofE-grade EBITDA. Where most sellers find out about the haircut in week 6 of diligence... too late.
Read →Almost every founder-built finance stack breaks somewhere between $20M and $40M in revenue. Three failure modes that always show up... and what to replace them with before the next capital event.
Read →Three places AI belongs in the CFO stack. Three places it doesn't. A skeptic's view from the operator who used it through diligence on a $95M sale.
Read →Pick a time that works. No prep needed. We'll talk about where the business is and where it's going.
Book a Discovery Call →Prefer to write first? Use the form on the right. The first conversation is a no-cost 30-minute discovery call. We'll talk about where the business is, where it's going, and whether what I do is the right fit. If it is, we'll scope from there. If not, I'll point you to someone who is.